← back to search

Kenneth E. Lipson

FibroGen (United States) · US
Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Connective Tissue Growth Factor Research, Angiogenesis and VEGF in Cancer, Pulmonary Hypertension Research and Treatments, and Immune Response and Inflammation.
h-index
51
citations
7,698
works
156
NIH funding
primary concept
email

Recent publications

Mechanical stress-induced connective tissue growth factor plays a critical role in intestinal fibrosis in Crohn's-like colitis.
2024cited by 8position: contributordoi
Connective-Tissue Growth Factor Contributes to TGF-β1-induced Lung Fibrosis.
2022cited by 77position: contributordoi
Driving fibrosis in neuromuscular diseases: Role and regulation of Connective tissue growth factor (CCN2/CTGF).
2021cited by 22position: contributordoi
Role of hypoxia in skeletal muscle fibrosis: Synergism between hypoxia and TGF-β signaling upregulates CCN2/CTGF expression specifically in muscle fibers.
2020cited by 52position: contributordoi
Late Intervention with Radiation-Induced Lung Fibrosis - Comparing Pamrevlumab Anti-CTGF Therapy vs. Pirfenidone vs. Nintedanib as Mono-, Dual- and Triple-therapy Combinations
International Journal of Radiation Oncology*Biology*Physics 2020cited by 3position: middledoi
Towards Better Definition, Quantification and Treatment of Fibrosis in Heart Failure. A Scientific Roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology
European Journal of Heart Failure 2019cited by 290position: middledoi
Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology.
2019cited by 219position: contributordoi
Denervation-induced skeletal muscle fibrosis is mediated by CTGF/CCN2 independently of TGF-β
Matrix Biology 2019cited by 90position: middledoi
Denervation-induced skeletal muscle fibrosis is mediated by CTGF/CCN2 independently of TGF-β.
2019cited by 66position: contributordoi
Connective Tissue Growth Factor Inhibition Enhances Cardiac Repair and Limits Fibrosis After Myocardial Infarction.
2019cited by 52position: contributordoi
Connective tissue growth factor (CTGF) methylation status is associated with prognosis of patients with head and neck squamous cell carcinoma (HNSCC) treated with radiochemotherapy (RCHT): A multicenter study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Journal of Clinical Oncology 2019cited by 0position: middledoi
Oncogene addiction and radiation oncology: effect of radiotherapy with photons and carbon ions in ALK-EML4 translocated NSCLC
Radiation Oncology 2018cited by 55position: middledoi
Radiation-induced pulmonary gene expression changes are attenuated by the CTGF antibody Pamrevlumab
Respiratory Research 2018cited by 25position: middledoi
Anti-connective tissue growth factor (CTGF/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosis
Arthritis Research & Therapy 2017cited by 83position: middledoi
Effects of CTGF Blockade on Attenuation and Reversal of Radiation-Induced Pulmonary Fibrosis
JNCI Journal of the National Cancer Institute 2016cited by 151position: middledoi
Synergistic effects of crizotinib and radiotherapy in experimental EML4–ALK fusion positive lung cancer
Radiotherapy and Oncology 2015cited by 52position: middledoi
Connective tissue growth factor regulates cardiac function and tissue remodeling in a mouse model of dilated cardiomyopathy
Journal of Molecular and Cellular Cardiology 2015cited by 33position: middledoi
Radiotherapy combined with TLR7/8 activation induces strong immune responses against gastrointestinal tumors
Oncotarget 2014cited by 65position: middledoi
Combined Inhibition of CTGF-Signaling and Radiation Therapy in Pancreatic Cancer
International Journal of Radiation Oncology*Biology*Physics 2014cited by 1position: middledoi
Multimodal Therapies for Pancreatic Cancer
Elsevier eBooks 2014cited by 0position: middledoi
Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy
Human Molecular Genetics 2013cited by 145position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Amir Abdollahi · German Cancer Research Center6 papers (2014–2020)Jürgen Debus · NYU Langone Health6 papers (2014–2020)Mahmoud Moustafa · Suez Canal University3 papers (2014–2020)Peter E. Huber · German Cancer Research Center3 papers (2014–2018)Cheng Zhou · Bengbu Medical College3 papers (2015–2020)Todd Seeley · FibroGen (United States)3 papers (2015–2018)Christian Schwager · German Cancer Research Center3 papers (2015–2019)Alexandra Tietz · Heidelberg University3 papers (2014–2018)Mark D. Sternlicht · FibroGen (United States)3 papers (2015–2018)Wilko Weichert · German Cancer Research Center3 papers (2014–2020)Quan-Xiang Wei · German Cancer Research Center2 papers (2015–2018)Elias Kouchakji · Amgen (United States)2 papers (2019–2020) · 2 papers (2019–2022)Sara Chiblak · German Cancer Research Center2 papers (2014–2014)Sebastian Bickelhaupt · Friedrich-Alexander-Universität Erlangen-Nürnberg2 papers (2016–2018)Ute Wirkner · German Cancer Research Center2 papers (2016–2018) · 2 papers (2013–2019) · 1 papers (2019–2019)Carmen Timke · St. Franziskus Hospital1 papers (2016–2016)Mark Kriegsmann · Zentrum für Pathologie und Zytodiagnostik1 papers (2020–2020)